Zurcher Kantonalbank (Zurich Cantonalbank) Athenex, Inc. Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$34.1 Billion
Q4 2024

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 01, 2022	SELL	$1.36 - $2.94 $11,206 - $24,225	-8,240 Closed	0 $0
Q4 2020 Jan 28, 2021	BUY	$11.06 - $14.01 $34,628 - $43,865	3,131 Added 61.28%	8,240 $91,000
Q1 2020 May 06, 2020	BUY	$5.71 - $15.85 $14,577 - $40,465	2,553 Added 99.88%	5,109 $40,000
Q3 2019 Oct 18, 2019	SELL	$12.16 - $21.0 $14,592 - $25,200	-1,200 Reduced 31.95%	2,556 $31,000
Q2 2019 Jul 30, 2019	BUY	$9.44 - $19.8 $19,474 - $40,847	2,063 Added 121.85%	3,756 $74,000
Q3 2018 Nov 09, 2018	BUY	$15.53 - $19.97 $26,292 - $33,809	1,693 New	1,693 $26,000

Others Institutions Holding ATNX

# of Institutions

Shares Held

1.46M

Call Options Held

Put Options Held

Empery Asset Management, LP New York, NY

1.45M
Shares

$14,521
2.33% of portfolio
Eaton Vance Management Boston, MA

12K
Shares

$120
0.0% of portfolio
Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

View Full List

About Athenex, Inc.

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

More about ATNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account